Article
Exome sequencing utility in defining the genetic landscape of hearing loss and novel-gene discovery in Iran.
Clinical genetics - 1 Jul 2021
Mohseni Marzieh, Babanejad Mojgan, Booth Kevin T, Jamali Payman, Jalalvand Khadijeh, Davarnia Behzad, Ardalani Fariba, Khoshaeen Atefeh, Arzhangi Sanaz, Ghodratpour Fatemeh, Beheshtian Maryam, Jahanshad Faezeh, Otukesh Hasan, Bahrami Fatemeh, Seifati Seyed Morteza, Bazazzadegan Niloofar, Habibi Farkhonde, Behravan Hanieh, Mirzaei Sepide, Keshavarzi Fatemeh, Nikzat Nooshin, Mehrjoo Zohreh, Thiele Holger, Nothnagel Michael, Azaiez Hela, Smith Richard J, Kahrizi Kimia, Najmabadi Hossein
Abstract excerpt
Hearing loss (HL) is one of the most common sensory defects affecting more than 466 million individuals worldwide. It is clinically and genetically heterogeneous with over 120 genes causing non-syndromic HL identified to date. Here, we performed exome sequencing (ES) on a cohort of Iranian families with no disease-causing variants in known deafness-associated genes after screening with a targeted gene panel. We...
Topics
Join the communities discussing this publication.
